SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 223 filers reported holding SEATTLE GENETICS INC in Q3 2015. The put-call ratio across all filers is 1.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $16,091,000 | +603.0% | 84,807 | +528.4% | 0.07% | +407.1% |
Q2 2020 | $2,289,000 | -5.6% | 13,496 | -36.5% | 0.01% | -26.3% |
Q1 2020 | $2,426,000 | +126.3% | 21,265 | +124.3% | 0.02% | +171.4% |
Q4 2019 | $1,072,000 | -87.0% | 9,480 | -91.1% | 0.01% | -86.3% |
Q3 2019 | $8,221,000 | -43.8% | 107,041 | -50.7% | 0.05% | -30.1% |
Q2 2019 | $14,635,000 | +226.9% | 216,959 | +275.8% | 0.07% | +170.4% |
Q1 2019 | $4,477,000 | +41.1% | 57,725 | +3.5% | 0.03% | +28.6% |
Q4 2018 | $3,172,000 | -29.1% | 55,778 | -3.4% | 0.02% | -19.2% |
Q3 2018 | $4,477,000 | +18.7% | 57,725 | +0.3% | 0.03% | +4.0% |
Q2 2018 | $3,772,000 | -12.6% | 57,545 | -30.6% | 0.02% | -16.7% |
Q1 2018 | $4,318,000 | +7.9% | 82,866 | -1.7% | 0.03% | -3.2% |
Q4 2017 | $4,002,000 | 0.0% | 84,337 | 0.0% | 0.03% | 0.0% |
Q3 2017 | $4,002,000 | -11.4% | 84,337 | -0.2% | 0.03% | -13.9% |
Q2 2017 | $4,516,000 | -16.7% | 84,501 | -1.5% | 0.04% | -28.0% |
Q1 2017 | $5,423,000 | +15.6% | 85,749 | -2.9% | 0.05% | 0.0% |
Q4 2016 | $4,691,000 | +167.9% | 88,350 | +168.9% | 0.05% | +163.2% |
Q3 2016 | $1,751,000 | -1.8% | 32,850 | -25.7% | 0.02% | -5.0% |
Q2 2016 | $1,784,000 | -11.8% | 44,200 | -26.5% | 0.02% | -16.7% |
Q1 2016 | $2,022,000 | -36.9% | 60,100 | -15.2% | 0.02% | -35.1% |
Q4 2015 | $3,203,000 | +32.2% | 70,900 | +12.9% | 0.04% | +23.3% |
Q3 2015 | $2,422,000 | -17.3% | 62,800 | +3.8% | 0.03% | -14.3% |
Q2 2015 | $2,928,000 | +42.1% | 60,500 | +3.8% | 0.04% | +34.6% |
Q1 2015 | $2,061,000 | -3.6% | 58,300 | -11.9% | 0.03% | -3.7% |
Q4 2014 | $2,137,000 | -20.5% | 66,200 | -8.4% | 0.03% | -25.0% |
Q3 2014 | $2,688,000 | -0.4% | 72,300 | +2.4% | 0.04% | -12.2% |
Q2 2014 | $2,700,000 | -20.0% | 70,600 | -4.7% | 0.04% | -24.1% |
Q1 2014 | $3,376,000 | +20.9% | 74,100 | +6.8% | 0.05% | +17.4% |
Q4 2013 | $2,792,000 | -5.9% | 69,400 | +2.5% | 0.05% | -11.5% |
Q3 2013 | $2,967,000 | – | 67,700 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |